Stock listing

NASDAQ:NRX NephroGenex Inc Stock

Follow NephroGenex Inc into a list and get an email when it puts out news.

Last close · NASDAQ:NRX

$0.14 USD

Close on May 10, 2016 · No longer trades

Feb 12, 2014 to last close -98.6% · weekly closes, Feb 12, 2014 – May 10, 2016
Lowest – highest close
$0.12 – $13.35 USDSince Feb 12, 2014 · lowest May 5, 2016 · highest Dec 31, 2014

Delisted NASDAQ:NRX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:NRX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

NephroGenex Inc on 6ix

Decks
14 decks · latest Jul 6, 2016

Decks

DeckKindSlidesDate
Investor Presentation (July 2016)Investor deck10 slidesJul 6, 2016
Investor Presentation (May 2016)Investor deck32 slidesMay 13, 2016
Investor Presentation (January 2016)Investor deck43 slidesJan 7, 2016
Investor Presentation (November 2015)Investor deck40 slidesNov 12, 2015
Investor Presentation (September 2015)Investor deck31 slidesSep 2, 2015
Investor Presentation (March 2015)Investor deck28 slidesMar 26, 2015
Investor Presentation (February 2015)Investor deck30 slidesFeb 24, 2015
Investor Presentation (January 2015)Investor deck29 slidesJan 6, 2015
Investor Presentation (December 2014)Investor deck29 slidesDec 11, 2014
Investor Presentation (September 2014)Investor deck25 slidesSep 2, 2014
All 14 decks
DeckKindSlidesDate
Investor Presentation (August 2014)Investor deck24 slidesAug 29, 2014
Investor Presentation (April 2014)Investor deck22 slidesApr 29, 2014
Investor Presentation (April 2014)Investor deck22 slidesApr 9, 2014
IPO Roadshow (January 2014)IPO roadshow33 slidesJan 21, 2014

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Pierre Legault
Other companies: Syndax Pharmaceuticals, Inc. (Director · Since at least Jan 4, 2017); Bicycle Therapeutics PLC (Director · May 22, 2019 – Jan 2, 2025 · Past); Urovant Sciences Ltd (Director · Sep 26, 2018 – Mar 29, 2021 · Past); Armo Biosciences Inc. (Director · Jan 25, 2018 – Mar 26, 2018 · Past); NPS Pharmaceuticals Inc (Director · Nov 3, 2014 – Feb 21, 2015 · Past); Tobira Therapeutics Inc (Director · Nov 18, 2013 – Nov 1, 2016 · Past); Forest Laboratories Inc (Director · Aug 15, 2013 – Jul 1, 2014 · Past)
Chief Executive Officer, Director · Feb 10, 2014 – Nov 10, 2015 · Past
Eugen SteinerDirector · Feb 10, 2014 – Dec 9, 2015 · Past

Open People

Log in to ask 6ix AI your own questions about NephroGenex Inc.